Free Trial

Opthea (NASDAQ:OPT) Trading 6.1% Higher - Time to Buy?

Opthea logo with Medical background

Opthea Limited (NASDAQ:OPT - Get Free Report)'s stock price rose 6.1% during trading on Thursday . The company traded as high as $3.81 and last traded at $3.81. Approximately 3,297 shares traded hands during trading, a decline of 87% from the average daily volume of 24,610 shares. The stock had previously closed at $3.59.

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group raised Opthea to a "strong-buy" rating in a research note on Tuesday, December 17th.

Read Our Latest Stock Analysis on OPT

Opthea Stock Up 4.0 %

The company's 50 day moving average price is $3.57 and its 200 day moving average price is $3.35.

Hedge Funds Weigh In On Opthea

An institutional investor recently bought a new position in Opthea stock. Jane Street Group LLC acquired a new stake in Opthea Limited (NASDAQ:OPT - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 26,632 shares of the company's stock, valued at approximately $114,000. Hedge funds and other institutional investors own 55.95% of the company's stock.

About Opthea

(Get Free Report)

Opthea Limited, a clinical stage biopharmaceutical company, engages in the development and commercialization of therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) VEGF-C, VEGF-D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage.

See Also

Should You Invest $1,000 in Opthea Right Now?

Before you consider Opthea, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Opthea wasn't on the list.

While Opthea currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025
Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines